{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:21:14Z","timestamp":1770690074893,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Molecular Life Sciences (MLS) of the University of Oslo National Research Council of Norway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Factor VII (FVII) activating protease (FSAP) is a circulating serine protease. Human genetic studies, based on the Marburg I (MI) (Gly221Glu, chymotrypsin numbering system) polymorphism, implicate FSAP in the pathogenesis of many diseases. Here, we describe the molecular and functional changes caused by the Gly221Glu substitution in the 220 loop using recombinant proteins expressed in <jats:italic>E. coli<\/jats:italic>. The serine protease domain (SPD) of wild type (WT) FSAP displayed auto-catalytic activation whereas the MI isoform displayed very low autocatalytic activation and low proteolytic activity against the chromogenic substrate S-2288, Factor VII, tissue factor pathway inhibitor as well as pro-urokinase. Introduction of a thermolysin cleavage site in the activation position (Arg15Gln) led to cleavage of both WT- and MI-SPD and the resulting WT-SPD, but not the MI-SPD, was active. Mutating the Gly221 position to Asp, Gln and Leu led to a loss of activity whereas the Ala substitution was partially active. These results suggest a disturbance of the active site, or non-accessibility of the substrate to the active site in MI-SPD. With respect to regulation with metal ions, calcium, more than sodium, increased the enzymatic activity of WT-SPD. Thus, we describe a novel method for the production of recombinant FSAP-SPD to understand the role of the MI-single nucleotide polymorphism (SNP) in the regulation of its activity.<\/jats:p>","DOI":"10.1038\/s41598-019-55531-x","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T15:11:38Z","timestamp":1576163498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP)"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6154","authenticated-orcid":false,"given":"Nis V.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfie","family":"Roedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-8250","authenticated-orcid":false,"given":"Dipankar","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Etscheid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Preben","family":"Morth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0782-9957","authenticated-orcid":false,"given":"Sandip M.","family":"Kanse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"55531_CR1","doi-asserted-by":"publisher","first-page":"21020","DOI":"10.1074\/jbc.M116.744631","volume":"291","author":"S Leiting","year":"2016","unstructured":"Leiting, S., Seidl, S., Martinez-Palacian, A., Muhl, L. & Kanse, S. M. Transforming Growth Factor-beta (TGF-beta) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes. The Journal of biological chemistry 291, 21020\u201321028, https:\/\/doi.org\/10.1074\/jbc.M116.744631 (2016).","journal-title":"The Journal of biological chemistry"},{"key":"55531_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/oxfordjournals.jbchem.a021362","volume":"119","author":"NH Choi-Miura","year":"1996","unstructured":"Choi-Miura, N. H. et al. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J Biochem (Tokyo) 119, 1157\u20131165 (1996).","journal-title":"J Biochem (Tokyo)"},{"key":"55531_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbrc.2011.05.030","volume":"409","author":"S Yamamichi","year":"2011","unstructured":"Yamamichi, S. et al. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun 409, 483\u2013488, https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.030 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"55531_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1515\/BC.2000.150","volume":"381","author":"M Etscheid","year":"2000","unstructured":"Etscheid, M., Hunfeld, A., Konig, H., Seitz, R. & Dodt, J. Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism. Biol Chem 381, 1223\u20131231 (2000).","journal-title":"Biol Chem"},{"key":"55531_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nature01962","volume":"425","author":"R Friedrich","year":"2003","unstructured":"Friedrich, R. et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425, 535\u2013539, https:\/\/doi.org\/10.1038\/nature01962 (2003).","journal-title":"Nature"},{"key":"55531_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/anie.200804695","volume":"48","author":"LM Salonen","year":"2009","unstructured":"Salonen, L. M. et al. Cation-pi interactions at the active site of factor Xa: dramatic enhancement upon stepwise N-alkylation of ammonium ions. Angew Chem Int Ed Engl 48, 811\u2013814, https:\/\/doi.org\/10.1002\/anie.200804695 (2009).","journal-title":"Angew Chem Int Ed Engl"},{"key":"55531_CR7","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1074\/jbc.M116.757849","volume":"292","author":"F Stavenuiter","year":"2017","unstructured":"Stavenuiter, F., Ebberink, E., Mertens, K. & Meijer, A. B. Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2. The Journal of biological chemistry 292, 6381\u20136388, https:\/\/doi.org\/10.1074\/jbc.M116.757849 (2017).","journal-title":"The Journal of biological chemistry"},{"key":"55531_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00001721-200207000-00008","volume":"13","author":"J Roemisch","year":"2002","unstructured":"Roemisch, J., Feussner, A., Nerlich, C., Stoehr, H. A. & Weimer, T. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis 13, 433\u2013441 (2002).","journal-title":"Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis"},{"key":"55531_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.thromres.2012.07.023","volume":"130","author":"M Etscheid","year":"2012","unstructured":"Etscheid, M. et al. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. Thrombosis research 130, 935\u2013941 (2012).","journal-title":"Thrombosis research"},{"key":"55531_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/01.CIR.0000055189.18831.B1","volume":"107","author":"J Willeit","year":"2003","unstructured":"Willeit, J. et al. Marburg I polymorphism of factor VII\u2013activating protease: a prominent risk predictor of carotid stenosis. Circulation 107, 667\u2013670 (2003).","journal-title":"Circulation"},{"key":"55531_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/hep.22707","volume":"49","author":"HE Wasmuth","year":"2009","unstructured":"Wasmuth, H. E. et al. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. Hepatology 49, 775\u2013780, https:\/\/doi.org\/10.1002\/hep.22707 (2009).","journal-title":"Hepatology"},{"key":"55531_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMoa1502449","volume":"373","author":"SK Gara","year":"2015","unstructured":"Gara, S. K. et al. Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer. The New England journal of medicine 373, 448\u2013455, https:\/\/doi.org\/10.1056\/NEJMoa1502449 (2015).","journal-title":"The New England journal of medicine"},{"key":"55531_CR13","doi-asserted-by":"publisher","first-page":"424759","DOI":"10.4061\/2011\/424759","volume":"2011","author":"S Trompet","year":"2011","unstructured":"Trompet, S. et al. Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality. Stroke Res Treat 2011, 424759, https:\/\/doi.org\/10.4061\/2011\/424759 (2011).","journal-title":"Stroke Res Treat"},{"key":"55531_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2012.09.007","volume":"58","author":"E Borkham-Kamphorst","year":"2013","unstructured":"Borkham-Kamphorst, E. et al. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men. J Hepatol 58, 104\u2013111, https:\/\/doi.org\/10.1016\/j.jhep.2012.09.007 (2013).","journal-title":"J Hepatol"},{"key":"55531_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/ejn.12830","volume":"41","author":"AU Joshi","year":"2015","unstructured":"Joshi, A. U. et al. Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice. Eur J Neurosci 41, 965\u2013975, https:\/\/doi.org\/10.1111\/ejn.12830 (2015).","journal-title":"Eur J Neurosci"},{"key":"55531_CR16","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/jth.13417","volume":"14","author":"JM Daniel","year":"2016","unstructured":"Daniel, J. M. et al. Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation. Journal of thrombosis and haemostasis: JTH 14, 2058\u20132067, https:\/\/doi.org\/10.1111\/jth.13417 (2016).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"55531_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1160\/TH14-06-0519","volume":"113","author":"S Subramaniam","year":"2015","unstructured":"Subramaniam, S. et al. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP). Thromb Haemost 113, 870\u2013880, https:\/\/doi.org\/10.1160\/TH14-06-0519 (2015).","journal-title":"Thromb Haemost"},{"key":"55531_CR18","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.febslet.2009.05.012","volume":"583","author":"L Muhl","year":"2009","unstructured":"Muhl, L., Hersemeyer, K., Preissner, K. T., Weimer, T. & Kanse, S. M. Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions. FEBS Lett 583, 1994\u20131998 (2009).","journal-title":"FEBS Lett"},{"key":"55531_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1538-7836.2012.04619.x","volume":"10","author":"F Stavenuiter","year":"2012","unstructured":"Stavenuiter, F. et al. Factor seven activating protease (FSAP): does it activate factor VII? Journal of thrombosis and haemostasis: JTH 10, 859\u2013866, https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04619.x (2012).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"55531_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1538-7836.2009.03641.x","volume":"8","author":"S Yamamichi","year":"2010","unstructured":"Yamamichi, S., Nishitani, M., Nishimura, N., Matsushita, Y. & Hasumi, K. Polyamine-promoted autoactivation of plasma hyaluronan-binding protein, a serine protease involved in extracellular proteolysis. Journal of thrombosis and haemostasis: JTH 8, 559\u2013566 (2010).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"55531_CR21","unstructured":"Perlmann, G. E. & Lorand, L. Methods in enzymology. Volume XIX. Proteolytic enzymes. Volume XIX. (New York, USA: Academic Press, 1970)."},{"key":"55531_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20061630","volume":"404","author":"L Muhl","year":"2007","unstructured":"Muhl, L. et al. Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP. Biochem J 404, 191\u2013196 (2007).","journal-title":"Biochem J"},{"key":"55531_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1182\/blood.V81.3.734.734","volume":"81","author":"JH Morrissey","year":"1993","unstructured":"Morrissey, J. H., Macik, B. G., Neuenschwander, P. F. & Comp, P. C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81, 734\u2013744 (1993).","journal-title":"Blood"},{"key":"55531_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1160\/TH11-12-0902","volume":"108","author":"S Peraramelli","year":"2012","unstructured":"Peraramelli, S., Suylen, D. P., Rosing, J. & Hackeng, T. M. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost 108, 266\u2013276, https:\/\/doi.org\/10.1160\/TH11-12-0902 (2012).","journal-title":"Thromb Haemost"},{"key":"55531_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods 12, 7\u20138, https:\/\/doi.org\/10.1038\/nmeth.3213 (2015).","journal-title":"Nat Methods"},{"key":"55531_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/prot.20264","volume":"57","author":"Y Zhang","year":"2004","unstructured":"Zhang, Y. & Skolnick, J. Scoring function for automated assessment of protein structure template quality. Proteins 57, 702\u2013710, https:\/\/doi.org\/10.1002\/prot.20264 (2004).","journal-title":"Proteins"},{"key":"55531_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/ATVBAHA.111.238394","volume":"32","author":"SM Kanse","year":"2012","unstructured":"Kanse, S. M., Declerck, P. J., Ruf, W., Broze, G. & Etscheid, M. Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor. Arteriosclerosis, thrombosis, and vascular biology 32, 427\u2013433, https:\/\/doi.org\/10.1161\/ATVBAHA.111.238394 (2012).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"55531_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0022-2836(79)90227-4","volume":"127","author":"W Bode","year":"1979","unstructured":"Bode, W. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen. Journal of molecular biology 127, 357\u2013374 (1979).","journal-title":"Journal of molecular biology"},{"key":"55531_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.thromres.2019.08.016","volume":"182","author":"W Rut","year":"2019","unstructured":"Rut, W. et al. Fluorescent activity-based probe for the selective detection of Factor VII activating protease (FSAP) in human plasma. Thrombosis research 182, 124\u2013132, https:\/\/doi.org\/10.1016\/j.thromres.2019.08.016 (2019).","journal-title":"Thrombosis research"},{"key":"55531_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2017.08.029","volume":"265","author":"K Byskov","year":"2017","unstructured":"Byskov, K. et al. Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells. Atherosclerosis 265, 133\u2013139, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.08.029 (2017).","journal-title":"Atherosclerosis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55531-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55531-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:18:06Z","timestamp":1671297486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55531-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55531"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55531-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18990"}}